Nurix Therapeutics, Inc. NRIX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

58/100

3/7 Pass

SharesGrow Intrinsic Value

Nurix Therapeutics, Inc. (NRIX) has 19 known insider and institutional holders on record. The largest holder is Third Rock Ventures III, L.P. with 3,422,549 shares. Other notable holders include SANDS ARTHUR T and DANSEY ROGER D.

Over the last 12 months, insiders have made 37 transactions in NRIX stock — 16 buys (valued at $11.8M) and 6 sells (valued at $696.33K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

NRIX Insider Ownership

Top Holder

Third Rock Ventures III, L.P.

3,422,549 shares

Buys (12 mo)

$11.8M value

Sells (12 mo)

$696.33K value

12-Month Transaction Activity

Buy 43%

Sell 16%

Top Insider Holders

#	Name	Role	Shares Owned	Last Filed	Relative Size
1	Third Rock Ventures Iii, L.p.	10 Percent Owner	3,422,549	2021-05-10	100%
2	Sands Arthur T	President, CEO	562,500	2026-02-10	16%
3	Dansey Roger D	Director	50,000	2025-11-10	1%
4	Hansen Gwenn	Chief Scientific Officer	42,875	2026-02-10	1%
5	Van Houte Hans	Chief Financial Officer	42,875	2026-02-10	1%
6	Ring Christine	Chief Legal Officer	26,453	2026-04-02	1%
7	Kunkel Lori Anne	Director	25,000	2025-05-19	1%
8	Reinsdorf Judith A	Director	25,000	2025-05-19	1%
9	Kapur Anil	Director	25,000	2025-05-19	1%
10	Silva Paul M	Director	25,000	2025-05-19	1%
11	Saltzman Edward C	Director	25,000	2025-05-19	1%
12	Lacey David L.	Director	25,000	2025-05-19	1%
13	Baynes Roy D.	Director	25,000	2025-05-19	1%
14	Siegall Clay B	Director	17,500	2022-05-06	1%
15	Chen Leon	Director	17,500	2021-05-24	1%
16	Tong Jeffrey K	10 Percent Owner	17,500	2021-05-24	1%
17	Gregory Julia P	Director	10,750	2025-09-17	0%
18	Wolff Stefani	EVP and COO	6,455	2023-05-02	0%
19	Beaurang Pierre	Chief Business Officer	4,330	2021-08-11	0%

Recent Transactions (last 12 months)

Date	Name	Role	Type	Shares	Price	Value
2026-04-02	Ring Christine	Chief Legal Officer	Informative Sell	8,148	$15.24	$124.15K
2026-03-02	Ring Christine	Chief Legal Officer	Informative Sell	8,148	$15.44	$125.79K
2026-02-10	Van Houte Hans	Chief Financial Officer	RSU Award	42,875	-	-
2026-02-10	Ring Christine	Chief Legal Officer	RSU Award	42,875	-	-
2026-02-10	Hansen Gwenn	Chief Scientific Officer	RSU Award	42,875	-	-
2026-02-10	Sands Arthur T	President, CEO	RSU Award	562,500	$16.45	$9.25M
2026-02-09	Ring Christine	Chief Legal Officer	Informative Sell	14,261	$16.66	$237.62K
2026-02-03	Hansen Gwenn	Chief Scientific Officer	Option Exercise (Sell)	31,333	$0.84	$26.32K
2026-01-30	Van Houte Hans	Chief Financial Officer	Option Exercise (Sell)	2,887	-	-
2026-01-30	Ring Christine	Chief Legal Officer	Option Exercise (Sell)	1,925	-	-
2026-01-30	Hansen Gwenn	Chief Scientific Officer	Option Exercise (Sell)	3,207	-	-
2026-01-20	Ring Christine	Chief Legal Officer	Option Exercise (Sell)	3,760	$1.86	$6.99K
2025-12-18	Ring Christine	Chief Legal Officer	Option Exercise (Sell)	3,760	$1.86	$6.99K
2025-11-24	Ring Christine	Chief Legal Officer	Option Exercise (Sell)	37,600	$1.86	$69.94K
2025-11-06	Dansey Roger D	Director	RSU Award	50,000	$12.52	$626K
2025-11-06	Dansey Roger D	Director	Unknown	-	-	-
2025-11-03	Van Houte Hans	Chief Financial Officer	Informative Sell	6,284	$12.56	$78.93K
2025-10-30	Van Houte Hans	Chief Financial Officer	Option Exercise (Sell)	2,886	-	-
2025-10-30	Ring Christine	Chief Legal Officer	Option Exercise (Sell)	1,924	-	-
2025-10-30	Hansen Gwenn	Chief Scientific Officer	Option Exercise (Sell)	3,207	-	-
2025-10-14	Hansen Gwenn	Chief Scientific Officer	RSU Award	20,000	-	-
2025-09-17	Gregory Julia P	Director	Option Exercise	10,750	$1.86	$20K
2025-08-01	Van Houte Hans	Chief Financial Officer	Informative Sell	5,402	$11.03	$59.6K
2025-07-30	Van Houte Hans	Chief Financial Officer	Option Exercise (Sell)	2,886	-	-
2025-07-30	Ring Christine	Chief Legal Officer	Option Exercise	1,924	-	-